Texas Medical Privacy Law: Rx Industry Seeks Amendment Before Sept. 1
Executive Summary
The pharmaceutical industry is attempting to amend a Texas medical privacy law that would restrict drug companies' use of patient information before the law's Sept. 1 compliance deadline
You may also be interested in...
Privacy Bill In California Could Preview Fights On “Opt Out,” State Preemption
Pharmaceutical companies and their agents would be required to allow patients to receive drugs even if patients do not consent to disclosure of their medical information under legislation pending in the California state assembly
HHS Privacy Rule Will Close “Loophole” On Drug Marketing To Patients
HHS' final privacy regulations will close a loophole that would have allowed pharmaceutical companies to obtain protected patient information from healthcare providers for purposes of marketing products directly to patients
Lilly Prozac
Email reminder service for fluoxetine patients who signed up at www.prozac.com ends due to low level of interest, Lilly says. A June 27 email announcing the end of the service inadvertently revealed email addresses of 600 program participants. Pediatric exclusivity for Prozac expires Aug. 2